StonvexLoading…
StonvexStonvexStonvexSide-by-side peer comparison: valuation, growth, margin, and Activity Index.
Theme: biotech, ai · 9 peers
Best-in-column highlighted in green, worst in red. Sorted by Activity Index.
| Rank | Ticker | Price | Day | Mkt Cap | P/E | P/S | Rev YoY | Gross M. | Activity Index |
|---|---|---|---|---|---|---|---|---|---|
| You | RXRX Recursion Pharmaceuticals | $3.04 | -0.33% | $1.6B | — | 24.4 | +11.1% | 7.2% | 40 |
| 1 | IOVA Iovance Biotherapeutics | $3.52 | -3.83% | $1.6B | — | 5.5 | +34.3% | 36.7% | 59 |
| 2 |
Fundamentals via Finnhub (TTM). Quotes near real-time. Activity Index is Stonvex's proprietary momentum/sentiment composite, not investment advice.
| $9.35 |
| +1.30% |
| $1.5B |
| — |
| 2.5 |
| -52.5% |
| 85.0% |
| 49 |
| 3 | ARDX Ardelyx | $6.46 | +1.25% | $1.6B | — | 3.6 | +18.2% | 92.5% | 29 |
| 4 | INBX INBX | $116.16 | -1.52% | $1.7B | — | 1230.7 | +550.0% | — | — |
| 5 | VCEL VCEL | $33.14 | +0.91% | $1.7B | 101.8 | 6.1 | +16.4% | 74.4% | — |
| 6 | NRIX NRIX | $16.00 | -1.11% | $1.7B | — | 23.3 | +27.2% | — | — |
| 7 | PGEN PGEN | $4.60 | +10.84% | $1.5B | — | 151.7 | +146.7% | 50.2% | — |
| 8 | GLUE GLUE | $18.68 | -1.48% | $1.6B | — | 37.3 | -73.1% | — | — |
| 9 | VIR VIR | $9.09 | -2.57% | $1.6B | — | 23.0 | -7.6% | 100.0% | — |